After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Allogene Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Allogene Therapeutics Inc is $276.42M. A total of 2.37 million shares were traded on the day, compared to an average of 2.98M shares.
In the most recent transaction, Beneski Benjamin Machinas bought 786 shares of ALLO for 1.22 per share on Nov 17 ’25. In a previous transaction on Oct 21 ’25, Parker Geoffrey M. sold 36,744 shares at 1.26 per share. ALLO shares that CHIEF FINANCIAL OFFICER owns now total 1,276,796.
Among the insiders who bought shares, Parker Geoffrey M. acquired of 36,744 shares on Oct 21 ’25 at a per-share price of $1.26. In another insider transaction, MESSEMER DEBORAH M. sold 36,885 shares at $1.42 per share on Jun 10 ’25. Company shares held by the Director now total 107,431.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ALLO has a high of $3.78 and a low of $0.86.
As of this writing, ALLO has an earnings estimate of -$0.23 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of -$0.18 per share and a lower estimate of -$0.42. The company reported an EPS of -$0.28 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ALLO’s latest balance sheet shows that the firm has $457.30M in Cash & Short Term Investments as of fiscal 2021. There were $73.13M in debt and $47.91M in liabilities at the time. Its Book Value Per Share was $1.41, while its Total Shareholder’s Equity was $925.20M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALLO is Buy with a score of 4.27.
